generic glp-1 agonist FDA Approves Version of Liraglutide Injection, a for Weight Loss glp-1 agonist weight loss medications
Description
Starting on January 1, 2027, the list price for these medications will drop to $675-per-month for each drug
Ellis S, Moser E, SnellBergeon JK, Rodionova A, Hazenfield R, Garg S
When compared with placebo, retatrutide achieved similar changes in baseline fasting glucose levels
Clinics (Sao Paulo) 2014;69(12):828834
The most common side effects of these drugs are mild gastrointestinal (GI) issues
The FLOW trial, with semaglutide in a population with type 2 diabetes and CKD, was the first RCT of GLP-1 RAs with a dedicated renal outcome
